Provided by Tiger Trade Technology Pte. Ltd.

Johnson & Johnson

235.27
-0.1500-0.06%
Pre-market: 235.580.3100+0.13%05:11 EDT
Volume:9.05M
Turnover:2.13B
Market Cap:566.83B
PE:21.33
High:236.00
Open:234.14
Low:232.24
Close:235.42
52wk High:251.71
52wk Low:141.50
Shares:2.41B
Float Shares:2.40B
Volume Ratio:0.98
T/O Rate:0.38%
Dividend:5.14
Dividend Rate:2.18%
EPS(TTM):11.03
EPS(LYR):11.03
ROE:35.03%
ROA:8.68%
PB:6.95
PE(LYR):21.32

Loading ...

Subcutaneous Rybrevant®▼ (Amivantamab) Approved by European Commission for Every-Three-Week and Every-Four-Week Dosing for Patients With Advanced Egfr-Mutated Non-Small Cell Lung Cancer

THOMSON REUTERS
·
Feb 24

J&J: Sc Amivantamab Is NOW Authorised for Use Across All Previously Approved Intravenous (Iv) Amivantamab Indications-Website

THOMSON REUTERS
·
Feb 24

European Commission approves expanded subcutaneous RYBREVANT dosing for EGFR-mutated NSCLC patients

Reuters
·
Feb 24

Johnson & Johnson Sued by Bayer for Alleged False Claims on NUBEQA

MT Newswires Live
·
Feb 23

Bayer files false advertising suit against J&J and Janssen Biotech

TIPRANKS
·
Feb 23

Bayer Ag - Lawsuit Asserts J&J Makes False Claims on Nubeqa®

THOMSON REUTERS
·
Feb 23

Bayer Ag - Lawsuit Seeks Injunctions and Damages

THOMSON REUTERS
·
Feb 23

Bayer sues J&J over Nubeqa advertising claims

Reuters
·
Feb 23

Blackstone Life Sciences and Johnson & Johnson sign AML drug co-funding deal

Reuters
·
Feb 23

Blackstone Life Sciences - Johnson & Johnson and Bxls to Jointly Finance a Portion of Bleximenib Trials

THOMSON REUTERS
·
Feb 23

Johnson & Johnson Says Long-Term Ulcerative Colitis Data Show Sustained Clinical, Endoscopic Remission

MT Newswires Live
·
Feb 23

Johnson And Johnson Weighs DePuy Sale As Governance Approach Shifts

Simply Wall St.
·
Feb 23

Johnson & Johnson announces new long-term data from Quasar LTE study

TIPRANKS
·
Feb 23

BRIEF-J&J Says Tremfya (Guselkumab) Long-Term Data Show Sustained Clinical And Endoscopic Remission In Ulcerative Colitis Through 3 Years

Reuters
·
Feb 21

J&J - Tremfya (Guselkumab) Long-Term Data Show Sustained Clinical and Endoscopic Remission in Ulcerative Colitis Through 3 Years

THOMSON REUTERS
·
Feb 21

Microsoft, Disney, Boeing, J&J, JPMorgan Insider Shock

TIPRANKS
·
Feb 21

Stocks Ex-Dividend February 24

Dow Jones
·
Feb 21

Dow Drops 125 Points On Losses In Shares Of Nike, Walmart

Dow Jones
·
Feb 21

J&J Eyes Mega Sale Of DePuy Synthes In Orthopedics Breakup Push

Benzinga_recent_news
·
Feb 20

Overnight Market Update: US Stocks Decline, Oil and Gold Advance, Trump Issues Iran Ultimatum, UK's Former Prince Andrew Released

Deep News
·
Feb 20